SecSonar.com

Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Marker Therapeutics, Inc. (MRKR) is a Biotechnology company based in US with a market capitalization of $17M. Free cash flow was negative at -$12T. This page tracks MRKR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 5 employees · IPO Jul 16, 2002

Valuation

Valuation & price

$1.42 · as of May 17, 2026 · -35.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.19$1.52$0.85Jul 25Dec 25Jul 26Jul 7, 25$1.57Jul 9, 25$1.81Jul 11, 25$1.71Jul 15, 25$1.57Jul 17, 25$1.92Jul 21, 25$1.53Jul 23, 25$1.60Jul 25, 25$1.56Jul 29, 25$1.41Jul 31, 25$1.40Aug 4, 25$1.24Aug 6, 25$1.21Aug 11, 25$1.19Aug 13, 25$1.29Aug 15, 25$1.26Aug 19, 25$1.13Aug 21, 25$1.21Aug 25, 25$1.26Aug 27, 25$0.94Aug 29, 25$0.93Sep 3, 25$0.87Sep 5, 25$0.90Sep 9, 25$0.85Sep 11, 25$0.97Sep 16, 25$0.99Sep 18, 25$0.96Sep 22, 25$0.90Sep 24, 25$0.92Sep 26, 25$0.95Sep 30, 25$0.89Oct 2, 25$0.91Oct 6, 25$1.08Oct 8, 25$1.08Oct 10, 25$1.01Oct 14, 25$1.06Oct 16, 25$1.03Oct 21, 25$1.04Oct 23, 25$0.99Oct 27, 25$1.02Oct 29, 25$0.97Oct 31, 25$0.99Nov 4, 25$0.90Nov 6, 25$0.88Nov 10, 25$0.97Nov 12, 25$0.94Nov 14, 25$0.92Nov 18, 25$1.01Nov 20, 25$0.99Nov 25, 25$1.10Nov 28, 25$1.24Dec 2, 25$1.19Dec 4, 25$1.42Dec 8, 25$1.42Dec 10, 25$1.45Dec 12, 25$1.47Dec 16, 25$1.27Dec 18, 25$1.26Dec 22, 25$1.42Dec 24, 25$1.39Dec 29, 25$1.52Jan 2, 26$1.54Jan 6, 26$1.86Jan 8, 26$2.07Jan 12, 26$1.83Jan 14, 26$1.82Jan 16, 26$1.81Jan 21, 26$2.19Jan 23, 26$2.10Jan 27, 26$1.80Jan 29, 26$1.61Feb 2, 26$1.71Feb 4, 26$1.82Feb 9, 26$1.48Feb 11, 26$1.46Feb 13, 26$1.43Feb 18, 26$1.50Feb 20, 26$1.45Feb 24, 26$1.63Feb 26, 26$1.58Mar 2, 26$1.40Mar 4, 26$1.44Mar 6, 26$1.38Mar 10, 26$1.41Mar 12, 26$1.35Mar 17, 26$1.36Mar 19, 26$1.32Mar 23, 26$1.31Mar 25, 26$1.34Mar 27, 26$1.30Mar 31, 26$1.30Apr 2, 26$1.32Apr 7, 26$1.39Apr 9, 26$1.75Apr 13, 26$1.74Apr 15, 26$1.58Apr 17, 26$1.66Apr 22, 26$1.54Apr 24, 26$1.40Apr 28, 26$1.42Apr 30, 26$1.46May 4, 26$1.56May 6, 26$1.46May 8, 26$1.46May 12, 26$1.44May 14, 26$1.46May 18, 26$1.39May 20, 26$1.41May 22, 26$1.40May 28, 26$1.51Jun 1, 26$1.52Jun 3, 26$1.45Jun 5, 26$1.42Jun 9, 26$1.41Jun 11, 26$1.37Jun 15, 26$1.35Jun 17, 26$1.35Jun 22, 26$1.37Jun 24, 26$1.31Jun 26, 26$1.32Jul 2, 26$1.47
$0.8552-week range$2.19
Loading valuation history…

Fundamentals

Key fundamentals

$17M

Market cap

—

Revenue growth (YoY)

-104.3%

Gross margin

-$12T

Free cash flow (USD)

-$16.1T

Net debt

Net cash position

70.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$183.1KFY 2018$206.0KFY 2019$213.2KFY 2020$466.8KFY 2021$1.2MFY 2022$3.5MFY 2023$3.3MFY 2024$6.6MFY 2025$0.00
$0$0

Free cash flow by year

2016 → 2025

FY 2016$-6.5MFY 2017$-8.4MFY 2018$-14.6MFY 2019$-18.7MFY 2020$-29.3MFY 2021$-30.4MFY 2022$-27.0MFY 2023$-16.4MFY 2024$-10.9MFY 2025$-12014.1B
-$6.5M-$12T

Gross margin by year

2021 → 2024

FY 2021-154.7%FY 2022-240.6%FY 2023-214.6%FY 2024-104.3%
-154.7%-104.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.16)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 4, 2026Filing

Questions

Frequently asked questions

What is Marker Therapeutics, Inc.'s market cap?

Marker Therapeutics, Inc. (MRKR) has a market capitalization of $17M.

What is MRKR's P/E ratio?

A meaningful P/E ratio is not available for MRKR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MRKR's price-to-book (P/B) ratio?

MRKR trades at 0.00 times book value per share.

When did Marker Therapeutics, Inc. last report earnings?

MRKR last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying MRKR stock?

SEC Form 4 filings show no open-market insider buys at Marker Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PTHS

Pelthos Therapeutics Inc.

$17.2M

APLM

Apollomics, Inc.

$16.5M

GRDX

GridAI Technologies Corp.

$18.4M

LGVN

Longeveron Inc.

$15.4M

PSTV

Plus Therapeutics, Inc.

$14.4M

TAOX

TAO Synergies Inc.

$14M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.